Oltmans Curtis Gale
CIK 0001714982
SVP, General CounselDirector
Filings
9
Latest Feb 4, 2026
Issuers covered
2
Showing
9 of 9
Page 1
Track record
1 of 1 open-market trades scored (100% price coverage). Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 1 | 100% | +19.8% | +19.8% | +19.8% | +19.8% |
| 90 days | 1 | 100% | +42.4% | +42.4% | +42.4% | +42.4% |
| 180 days | - | - | - | - | - | - |
| 365 days | - | - | - | - | - | - |
Issuers
Companies where Oltmans Curtis Gale has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| FULC | Fulcrum Therapeutics, Inc. | 7 | Feb 4, 2026 |
| ATXI | Avenue Therapeutics, Inc. | 2 | Sep 25, 2024 |
All filings
9 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|